Yalamarty, S.S.K.; Filipczak, N.; Li, X.; Pathrikar, T.V.; Cotter, C.; Torchilin, V.P.
Co-Delivery of siRNA and Chemotherapeutic Drug Using 2C5 Antibody-Targeted Dendrimer-Based Mixed Micelles for Multidrug Resistant Cancers. Pharmaceutics 2022, 14, 1470.
https://doi.org/10.3390/pharmaceutics14071470
AMA Style
Yalamarty SSK, Filipczak N, Li X, Pathrikar TV, Cotter C, Torchilin VP.
Co-Delivery of siRNA and Chemotherapeutic Drug Using 2C5 Antibody-Targeted Dendrimer-Based Mixed Micelles for Multidrug Resistant Cancers. Pharmaceutics. 2022; 14(7):1470.
https://doi.org/10.3390/pharmaceutics14071470
Chicago/Turabian Style
Yalamarty, Satya Siva Kishan, Nina Filipczak, Xiang Li, Tanvi Vinod Pathrikar, Colin Cotter, and Vladimir P. Torchilin.
2022. "Co-Delivery of siRNA and Chemotherapeutic Drug Using 2C5 Antibody-Targeted Dendrimer-Based Mixed Micelles for Multidrug Resistant Cancers" Pharmaceutics 14, no. 7: 1470.
https://doi.org/10.3390/pharmaceutics14071470
APA Style
Yalamarty, S. S. K., Filipczak, N., Li, X., Pathrikar, T. V., Cotter, C., & Torchilin, V. P.
(2022). Co-Delivery of siRNA and Chemotherapeutic Drug Using 2C5 Antibody-Targeted Dendrimer-Based Mixed Micelles for Multidrug Resistant Cancers. Pharmaceutics, 14(7), 1470.
https://doi.org/10.3390/pharmaceutics14071470